I am a board-certified medical oncologist with expertise in breast cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and chronic lymphocytic leukemia. I am a member of MSK’s breast cancer and lymphoma disease management teams.
After completing oncology and hematology training at MSK, I joined the team at MSK Rockville Centre when it opened, in 1998. My colleagues and I offer a multidisciplinary approach utilizing the most recent advanced treatments in medical oncology and state-of-the-art radiation oncology. We also offer novel chemotherapy, targeted therapies, and monoclonal antibody therapies as well as genetic testing — which can help individualize treatment — closer to home.
As part of our research efforts, we are actively enrolling patients in a growing number of clinical trials at MSK Rockville Centre, allowing patients to receive the most advanced care closer to home on Long Island. We offer a warm, intimate environment, where doctors, nurses, and support staff collaborate with local physicians and facilities to take care of the medical, social, nutritional, and psychological needs of our patients.
- Clinical Expertise: Breast Cancer; Hematologic Malignancies
- Languages Spoken: English; Spanish
- Education: MD, Sackler School of Medicine (Tel Aviv)
- Residencies: Mount Sinai Medical Center (New York)
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Medical Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Pamela R. Drullinsky
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more